The HPV status appears to be related to the therapeutic outcome with regard to AREG; it was shown that HPV-positive HNSCC showed increased susceptibility to sorafenib and sunitinib, leading to a suppression of AREG expression [53]. The gene discussed is AREG; the disease is head and neck squamous cell carcinoma.